UCD Charles Institute of Dermatology Governance Board: From left front: Eoin O’Brien, Bill Powderly (replaced upon his departure in Jan 2013 by Patrick Murray), Frank Powell, Peter O’Flanagan. From left back: John Lynch, Desmond Fitzgerald, Risteard O’Laoide and Michael Griffith.
Desmond Fitzgerald is the Vice-President for Research and Professor of Molecular Medicine at UCD. He is a Fellow of the American Heart Association, the Royal College of Physicians of Ireland and the European Society of Cardiology, and was elected to the Association of American Physicians in 2006.
Peter O’Flanagan has spent his working life in the sales and marketing of construction equipment. He served as Treasurer and Vice Chairman of the Board before serving a four year term as Chairman from 2007 to 2011, during which time the Charles Institute, the Charles Centre and the Irish Skin Foundation were founded.
Eoin O’Brien is Professor of Molecular Pharmacology at University College Dublin and has been involved with the City of Dublin Skin and Cancer Hospital since childhood as his parents were members of the staff, as was he in later years. He has written the history of the hospital: A Century of Service. The City of Dublin Skin and Cancer Hospital 1911-2012 and is member of the Board of the Charles Institute and Chairman of the Irish Skin Foundation.
Laurent Perret, who has doctorates in physiology and paediatrics, started his hospital and university career in Paris where he was Assistant Professor until he joined Servier Laboratories in 1981, where he has been Clinical Research Director and President of Research and Development from 1990 to 2007. He is currently President of the Scientific Committee of the Servier Research Group and is also Research Professor in Neurosciences at the New York University.
Patrick Murray is Professor of Clinical Pharmacology in University College Dublin, and a consultant physician (clinical pharmacologist & nephrologist) at the Mater Misericordiae University Hospital, Dublin, Ireland. He received his medical education at University College Dublin, Ireland.
Following his internship at the Mater Misericordiae University Hospital in Dublin, he completed a residency in internal medicine at Hennepin County Medical Center in Minneapolis, Minnesota, USA. He completed fellowship training programs in nephrology, critical care medicine, and clinical pharmacology at the University of Chicago Hospitals in Chicago, Illinois, USA.
He is board-certified in internal medicine, nephrology, critical care medicine, and clinical pharmacology. He practiced as an intensivist, nephrologist, and clinical pharmacologist at the University of Chicago Hospitals from 1996–2008, serving as the fellowship training program director in nephrology, also directing the Acute Dialysis Service.
He has a longstanding interest in research and education to improve the prevention, diagnosis, and therapy of acute kidney injury and nephrotoxicity, and the pharmacotherapy of patients with kidney disease. He is a member of several international consensus groups that have produced guidelines for research and practice in the field of acute kidney injury (ADQI, AKIN, KDOQI).
Since 2008, he has been the Professor of Clinical Pharmacology at University College Dublin, and a Consultant in Nephrology & Clinical Pharmacology at the Mater Misericordiae University Hospital. He is Chair of the Mater Misericordiae University Hospital Drugs & Therapeutics Committee. He is the Clinical Director of the UCD-Mater Clinical Research Centre. In 2011, he was appointed Associate Dean for International Affairs in the UCD School of Medicine and Medical Science. In 2012, he was appointed Director of the Dublin Centre for Clinical Research (DCCR) Consortium Network. In December 2012, he was appointed Interim Dean and Head of the School of Medicine & Medical Science at UCD.
John Lynch is a business consultant to the pharmaceutical, medical device and diagnostics industry, having built businesses both in the multinational and indigenous sectors over the last 25 years in the USA, UK and Ireland. Until 2011 he was CEO of an Irish plc and prior to that he was a senior executive with Abbott Laboratories Inc. He attended UCD, the Institute of Chartered Accountants in Ireland, the Marketing Institute of Ireland and Stanford University.
Risteárd Ó Laoide is a consultant radiologist at St Vincent’s University Hospital, Associate Clinical Professor of Radiology at UCD and a board member of Dublin Academic Medical Centre. He has previously held the offices of chairman of the Medical Board SVUH, clinical director of St Vincent’s Healthcare Group and dean of the Faculty of Radiologists, Royal College of Surgeons in Ireland.
Colm Darling is Chairman of DEBRA Ireland which is the national charity established in 1988 to provide patient support services and to drive research into treatments and cures for those living with the genetic skin condition, epidermolysis bullosa (EB). He joined the charity following a career in banking and financial markets, offering experience achieved through diverse board and senior management positions in private and semi-state organisations.
Professor Frank Powell is a dermatologist and Chairman of the Board of Directors of the Charles Institute and acting Director.He is currently the President of the European Academy of Dermatology and Venereology and is a Past-President of the Irish Association of Dermatologists. He is a member of several international dermatologic societies and honorary member of the American Dermatologic Association, and the Hungarian and Romanian Dermatology Associations.
Professor Hall is Chair of Medical Microbiology, School of Medicine and Director of the Centre for Research into Infectious Diseases, both at University College Dublin. He is a Consultant Microbiologist at St. Vincent’s University Hospital.
He is an expert in infectious diseases and virology, and in the roles of viruses in the development of leukaemia and lymphoma. Prior to his tenure at University College Dublin, he was Professor and Head of the Laboratory of Medical Virology, Senior Physician and Director of the Clinical Research Centre at the Rockefeller University in New York. Earlier, he was an Assistant and Associate Professor of Medicine at Cornell University.
Professor Hall is a Consultant to the Irish Minister for Health and Children, Mary Harney TD, providing input on a number of topics, including influenza pandemic preparedness and bioterrorism, and he is a member of the National Public Health Emergency Team. He was Ireland’s Project Coordinator for the Ireland-Vietnam Blood Borne Virus Initiative, a project supported by Irish Aid and The Atlantic Philanthropies. Professor Hall is Chair of the Technical Advisory Group (TAG) of Irish Aid, which advises the Minister of State in the Department of Foreign Affairs of the Irish Government on overseas development aid.
His research has been published extensively in more than ten book chapters and 200 peer-reviewed and other journal articles. Professor Hall currently serves on the editorial boards of Journal of NeuroVirology, AIDS Research and Human Retroviruses, Neuropathology, and the Journal of the Acquired Immunodeficiency Syndrome (JAIDS). He was a Director of Amarin Corporation plc and President of the International Retrovirology Association. He was elected a Fellow of the American Academy of Microbiology.
Professor Hall earned his B.Sc. and Ph.D. from Queen’s University Belfast and his M.D. from Cornell University Medical College in New York. He is a Fellow of the Royal College of Physicians in the UK and in Ireland and is board certified in internal medicine and infectious diseases in the United States.